UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014

Antimicrobial agents and chemotherapy, 2017-04, Vol.61 (4)

2017

Volltextzugriff (PDF)

In Vitro Activity of the Novel Lactone Ketolide Nafithromycin (WCK 4873) against Contemporary Clinical Bacteria from a Global Surveillance Program

Antimicrobial agents and chemotherapy, 2017-12, Vol.61 (12)

2017

Volltextzugriff (PDF)

Gepotidacin (GSK2140944) In Vitro Activity against Gram-Positive and Gram-Negative Bacteria

Antimicrobial agents and chemotherapy, 2017-07, Vol.61 (7)

2017

Volltextzugriff (PDF)

In Vitro Activity of Gepotidacin (GSK2140944) against Neisseria gonorrhoeae

Antimicrobial agents and chemotherapy, 2017-03, Vol.61 (3)

2017

Volltextzugriff (PDF)

Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001–2004)

Clinical microbiology and infection, 2006-04, Vol.12 (4), p.315-321

2006

Volltextzugriff (PDF)

Emerging Importance of Multidrug-Resistant Acinetobacter Species and Stenotrophomonas maltophilia as Pathogens in Seriously Ill Patients: Geographic Patterns, Epidemiological Features, and Trends in the SENTRY Antimicrobial Surveillance Program (1997–1999)

Clinical infectious diseases, 2001-05, Vol.32 (Supplement-2), p.S104-S113

2001

Volltextzugriff (PDF)

Pharmacokinetic-Pharmacodynamic Evaluation of Ertapenem for Patients with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia

Antimicrobial agents and chemotherapy, 2019-06, Vol.63 (6)

2019

Volltextzugriff (PDF)

Antimicrobial susceptibility of Gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002–2004)

Clinical microbiology and infection, 2006-09, Vol.12 (9), p.844-852

2006

Volltextzugriff (PDF)

Erratum for Pfaller et al., " In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014"

Antimicrobial agents and chemotherapy, 2018-02, Vol.62 (2)

2018

Volltextzugriff (PDF)

Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998

Antimicrobial Agents and Chemotherapy, 2000-03, Vol.44 (3), p.747-751

2000

Volltextzugriff (PDF)

International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program

Journal of clinical microbiology, 2001-09, Vol.39 (9), p.3254-3259

2001

Volltextzugriff (PDF)

Antimicrobial Activity of Tigecycline and Cefoperazone/Sulbactam Tested against 18,386 Gram-negative Organisms from Europe and the Asia-Pacific Region (2013–2014)

Diagnostic microbiology and infectious disease, 2017-06, Vol.88 (2), p.177-183

2017

Volltextzugriff (PDF)

Complex Clonal and Plasmid Epidemiology in the First Outbreak of Enterobacteriaceae Infection Involving VIM-1 Metallo-β-Lactamase in Spain: Toward Endemicity?

Clinical infectious diseases, 2007-11, Vol.45 (9), p.1171-1178

2007

Volltextzugriff (PDF)

Survey of Bloodstream Infections Due to Gram-Negative Bacilli: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States,Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997

Clinical infectious diseases, 1999-09, Vol.29 (3), p.595-607

1999

Volltextzugriff (PDF)

Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09)

Journal of antimicrobial chemotherapy, 2011-09, Vol.66 (9), p.2070-2074

2011

Volltextzugriff (PDF)

Metallo-β-Lactamase Gene blaIMP-15 in a Class 1 Integron, In95, from Pseudomonas aeruginosa Clinical Isolates from a Hospital in Mexico

Antimicrobial Agents and Chemotherapy, 2008-08, Vol.52 (8), p.2943-2946

2008

Volltextzugriff (PDF)

Impact of EUCAST, CLSI and USCAST ceftaroline breakpoint changes on the susceptibility of methicillin-resistant Staphylococcus aureus isolates collected from US medical centres (2015–2018)

Clinical microbiology and infection, 2020-05, Vol.26 (5), p.658-659

2020

Volltextzugriff (PDF)

IMPs, VIMs and SPMs: the diversity of metallo-β-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital

Clinical microbiology and infection, 2005-01, Vol.11 (1), p.73-76

2005

Volltextzugriff (PDF)

Eight-year (2002-2009) Summary of the Linezolid (Zyvox® Annual Appraisal of potency and Spectrum; ZAAPS) Program in European Countries

Journal of chemotherapy (Florence), 2011-04, Vol.23 (2), p.71-76

2011

Volltextzugriff (PDF)

International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and Antifungal Susceptibilities of Isolates Collected in 1997 in the United States, Canada, and South America for the SENTRY Program

Journal of Clinical Microbiology, 1998-07, Vol.36 (7), p.1886-1889

1998

Volltextzugriff (PDF)

Antimicrobial Activity of Daptomycin Tested Against Gram-Positive Strains Collected in European Hospitals: Results from 7 Years of Resistance Surveillance (2003-2009)

Journal of chemotherapy (Florence), 2011-08, Vol.23 (4), p.200-206

2011

Volltextzugriff (PDF)

blaVIM₋₂ and blaVIM₋₇ Carbapenemase-Producing Pseudomonas aeruginosa Isolates Detected in a Tertiary Care Medical Center in the United States: Report from the MYSTIC Program

Journal of Clinical Microbiology, 2007-02, Vol.45 (2), p.614-615

2007

Volltextzugriff (PDF)

Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013–2015)

International journal of antimicrobial agents, 2018-02, Vol.51 (2), p.181-189

2018

Volltextzugriff (PDF)

Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres

Clinical microbiology and infection, 2005-02, Vol.11 (2), p.95-100

2005

Volltextzugriff (PDF)

Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches

Antimicrobial agents and chemotherapy, 2023-04, Vol.67 (4), p.e0145222-e0145222

2023

Volltextzugriff (PDF)

1 – 25 von 562

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(507)
Mit Volltextzugriff
(461)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014

In Vitro Activity of the Novel Lactone Ketolide Nafithromycin (WCK 4873) against Contemporary Clinical Bacteria from a Global Surveillance Program

Gepotidacin (GSK2140944) In Vitro Activity against Gram-Positive and Gram-Negative Bacteria

In Vitro Activity of Gepotidacin (GSK2140944) against Neisseria gonorrhoeae

Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001–2004)

Emerging Importance of Multidrug-Resistant Acinetobacter Species and Stenotrophomonas maltophilia as Pathogens in Seriously Ill Patients: Geographic Patterns, Epidemiological Features, and Trends in the SENTRY Antimicrobial Surveillance Program (1997–1999)

Pharmacokinetic-Pharmacodynamic Evaluation of Ertapenem for Patients with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia

Antimicrobial susceptibility of Gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002–2004)

Erratum for Pfaller et al., " In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014"

Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998

International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program

Antimicrobial Activity of Tigecycline and Cefoperazone/Sulbactam Tested against 18,386 Gram-negative Organisms from Europe and the Asia-Pacific Region (2013–2014)

Complex Clonal and Plasmid Epidemiology in the First Outbreak of Enterobacteriaceae Infection Involving VIM-1 Metallo-β-Lactamase in Spain: Toward Endemicity?

Survey of Bloodstream Infections Due to Gram-Negative Bacilli: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States,Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997

Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09)

Metallo-β-Lactamase Gene blaIMP-15 in a Class 1 Integron, In95, from Pseudomonas aeruginosa Clinical Isolates from a Hospital in Mexico

Impact of EUCAST, CLSI and USCAST ceftaroline breakpoint changes on the susceptibility of methicillin-resistant Staphylococcus aureus isolates collected from US medical centres (2015–2018)

IMPs, VIMs and SPMs: the diversity of metallo-β-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital

Eight-year (2002-2009) Summary of the Linezolid (Zyvox® Annual Appraisal of potency and Spectrum; ZAAPS) Program in European Countries

International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and Antifungal Susceptibilities of Isolates Collected in 1997 in the United States, Canada, and South America for the SENTRY Program

Antimicrobial Activity of Daptomycin Tested Against Gram-Positive Strains Collected in European Hospitals: Results from 7 Years of Resistance Surveillance (2003-2009)

blaVIM₋₂ and blaVIM₋₇ Carbapenemase-Producing Pseudomonas aeruginosa Isolates Detected in a Tertiary Care Medical Center in the United States: Report from the MYSTIC Program

Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013–2015)

Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres

Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches

Suchergebnisse filtern